Clinical Trial Update: Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating mesenchymal stem cells for perianal fistulizing Crohn's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Anthony Lembo | Conditions: Perianal Crohn Disease, Perianal Fistula | Phase 1, Phase 2 | Status: TERMINATED